← Back to the lab

Research group

Spleen, Red cell Aging & Transfusion group

Led by Pascal Amireault

4 members 2 research topics 8 selected publications

About the group

Research focus and expertise

The research activity of the Spleen, Red cell Aging & Transfusion group aims to develop a detailed molecular and cellular understanding of the physiological aging of mature red blood cells (RBCs), leading to their senescence and subsequent clearance from circulation by the spleen, a process which differs from the final elimination of nucleated eukaryotic cells that are not permanently circulating. This work has direct application in transfusion medicine, where the complex logistics of the transfusion chain are facilitated by the possibility of storing RBCs after blood collection. RBCs however continue to age during this period, leading to a degradation of their cellular properties. This degradation, or storage lesion, needs to be considered, and requires the management of post-transfusion complications such as reduced transfusion efficacy, which can ultimately lead to iron overload in chronically transfused patients. The knowledge generated our research is also relevant in a wide spectrum of pathophysiological contexts that cause anemia, such as hemoglobinopathies. Part of our research activity is conducted at the Imagine Institute (https://www.institutimagine.org/fr/olivier-hermine-181) where mouse models are developed to investigate RBC aging & clearance in vivo.

Research topics

01

The mature red blood cell: a cellular model to study age-related protein quality control dysfunction

Proteins in mature, organelle-devoid RBCs experience oxidative damage during their lifespan; however, they cannot synthesize new proteins to replace damaged components. This observation is particularly relevant in the pathophysiological context of beta-thalassemia, where misfolded toxic alpha-globin chains accumulate leading to reduced circulation quality in vivo. Also, in transfusion medicine, donated RBCs prematurely age in vitro during refrigerated storage leading to reduced storage quality. Therefore, protein quality control mechanisms (e.g., amino acid repair, chaperone-mediated refolding, proteasomal degradation) enable RBCs to respond to these attacks and determine their fate. In particular, because ATP fuels protein quality control, RBCs must maintain ATP levels. Building on our novel findings regarding proteasomal function in RBC biology (Peltier, Marin et al., Journal of Clin Invest, 2025), we will study interactions between oxidative damage and protein quality control mechanisms in RBCs, in vivo and in vitro. Leveraging these findings will identify novel ways to maintain and improve RBC properties with the long-term goals of improving transfusion efficacy and reducing hemolysis in the physio-pathological context of beta-thalassemia.

02

Red blood cell aging during blood banking: applied research in transfusion medicine

In the context of transfusion medicine, RBCs are stored as RBC concentrates at 4°C in a storage solution (SAGM) for up to 6 weeks. In Europe, hemolysis is the only in vitro marker of storage quality required for any new storage process for RBC concentrates, and must be less than 0.8% at expiry. However, hemolysis is not correlated with transfusion recovery and therefore does not directly assess the cellular properties of RBCs that determine transfusion efficacy. Our recent work has demonstrated that quantification of Storage-induced MicroErythrocytes (SMEs) by imaging flow cytometry (Roussel, Morel, Dussiot et al., Blood, 2021) or flow cytometry (Marin et al., Front Physiol, 2022) is a physiologically-relevant in vitro marker since it directly quantifies the subpopulation of senescent RBCs that are preferentially cleared from the recipient circulation after transfusion.

This field of research is necessary to ensure a safe and efficient supply of RBC concentrates and to assess regulatory or technological evolutions. In addition, although each RBC concentrate is currently considered to be of equal quality, regardless of the donor or storage time, and can be used in all indications, progress in research would allow transfusion medicine to evolve towards personalized medicine.

Selected publications

  1. The Proteasome Safeguards Red Blood Cell Integrity During Storage and After Transfusion

    Sandy Peltier, Théo Michel, Fanny Mialane, Mickaël Marin, Michaël Dussiot, Céline Rodriguez, Monika Dzieciatkowska, Marie Tamagne, Camille Roussel, Stéphanie Vicca, Olivier Hermine, Pierre A. Buffet, Benoit Vingert, Steven L. Spitalnik, Angelo D’Alessandro, Michel Prudent, Pascal Amireault

    Antioxidants, 15, 1146 (2026)

    DOI Link

  2. Proteostasis and metabolic dysfunction characterize a subset of storage-induced senescent erythrocytes targeted for posttransfusion clearance.

    Sandy Peltier, Mickaël Marin, Monika Dzieciatkowska, Michaël Dussiot, Micaela Kalani Roy, Johanna Bruce, Louise Leblanc, Youcef Hadjou, Sonia Georgeault, Aurélie Fricot, Camille Roussel, Daniel Stephenson, Madeleine Casimir, Abdoulaye Sissoko, François Paye, Safi Dokmak, Papa Alioune Ndour, Philippe Roingeard, Emilie-Fleur Gautier, Steven L Spitalnik, Olivier Hermine, Pierre A Buffet, Angelo D’Alessandro, Pascal Amireault

    J Clin Invest, 135 (2025)

    DOI Link

  3. Exposure to sub-zero temperatures down to -11 °C does not impact packed red cells storage quality

    Clément Derkenne, Manon Vavasseur, Olivier Javaudin, Yann Daniel, Simon-Pierre Corcostegui, Paul Lely, Elodie Ormes, Hélène Desudde, Sandrine Pons, Angela Giannuzzo, Matthieu Heidet, Philippe Vest, Daniel Jost, Michael Dussiot, Albane Miron de l’Espinay, Christophe Martinaud, Pascal Amireault

    Sci Rep., 15 (2025)

    DOI Link

  4. Metabolic rejuvenation upgrades circulatory functions of red blood cells stored under blood bank conditions.

    Marin Mickaël, Roussel Camille, Dussiot Michael, <b>Ndour Papa A</b>, Hermine Olivier, Colin Yves, Gray Alan, Landrigan Matt, Le Van Kim Caroline, Buffet Pierre A, Amireault Pascal

    Transfusion, 61 (2021)

    DOI

  5. Rapid clearance of storage-induced microerythrocytes alters transfusion recovery.

    Roussel Camille*, Morel Alexandre*, Dussiot Michaël*, Marin Mickaël, Colard Martin, Fricot-Monsinjon Aurélie, Martinez Anaïs, Chambrion Charlotte, Henry Benoît, Casimir Madeleine, Volle Geoffroy, Dépond Mallorie, Dokmak Safi, Paye François, Sauvanet Alain, Le Van Kim Caroline, Colin Yves, Georgeault Sonia, Roingeard Philippe, Spitalnik Steven L, Ndour Papa Alioune, Hermine Olivier, Hod Eldad A, Buffet Pierre A**, Amireault Pascal**

    Blood, 137 (2021)

    DOI

  6. Fluorescence Exclusion: A Simple Method to Assess Projected Surface, Volume and Morphology of Red Blood Cells Stored in Blood Bank.

    Roussel Camille, Monnier Sylvain, Dussiot Michael, Farcy Elisabeth, Hermine Olivier, Le Van Kim Caroline, Colin Yves, Piel Matthieu, Amireault Pascal, Buffet Pierre A

    Frontiers in medicine, 5 (2018)

    DOI

  7. Measuring Post-transfusion Recovery and Survival of Red Blood Cells: Strengths and Weaknesses of Chromium-51 Labeling and Alternative Methods.

    Roussel Camille, Buffet Pierre A, Amireault Pascal

    Frontiers in medicine, 5 (2018)

    DOI

  8. Spherocytic shift of red blood cells during storage provides a quantitative whole cell-based marker of the storage lesion.

    Roussel Camille, Dussiot Michaël, Marin Mickaël, Morel Alexandre, Ndour Papa Alioune, Duez Julien, Le Van Kim Caroline, Hermine Olivier, Colin Yves, Buffet Pierre A, Amireault Pascal

    Transfusion, 57 (2017)

    DOI